Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation

Journal of Nuclear Cardiology - Tập 24 Số 1 - Trang 86-99 - 2017
Michael T. Osborne1, Edward Hulten2, Venkatesh L. Murthy3, Hicham Skali4, Viviany R. Taqueti4, Sharmila Dorbala4, Marcelo F. DiCarli4, Ron Blankstein4
1Cardiology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA USA
2Cardiology Service, Division of Medicine, Walter Reed National Military Medical Center and Uniformed Services University of Health Sciences, Bethesda, MD, USA
3Division of Cardiovascular Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI, USA
4Non-Invasive Cardiovascular Imaging Program, Departments of Medicine and Radiology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis St, Boston, MA, 02115, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Blankstein, 2015, Proceedings of the ASNC cardiac PET summit meeting, May 12 2014, Baltimore MD, J Nucl Cardiol, 22, 720, 10.1007/s12350-015-0210-8

Cautela, 2013, Diagnostic yield of FDG positron-emission tomography/computed tomography in patients with CEID infection: A pilot study, Europace, 15, 252, 10.1093/europace/eus335

Saby, 2013, Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: Increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion, J Am Coll Cardiol, 61, 2374, 10.1016/j.jacc.2013.01.092

Blankstein, 2014, Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis, J Am Coll Cardiol, 21, 166

Morooka, 2014, Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesion of cardiac sarcoidosis, EJNMMI Res, 4, 1, 10.1186/2191-219X-4-1

Manabe, 2016, J Nucl Cardiol, 23, 244, 10.1007/s12350-015-0226-0

Demeure, 2014, A randomized trial on the optimization of 18F-FDG myocardial uptake suppression: Implications for vulnerable coronary plaque imaging, J Nucl Med, 55, 1629, 10.2967/jnumed.114.138594

Wykrzykowska, 2009, Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation, J Nucl Med, 50, 563, 10.2967/jnumed.108.055616

Depre, 1999, Glucose for the heart, Circulation, 99, 578, 10.1161/01.CIR.99.4.578

Mochizuki, 2001, FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models, J Nucl Med, 42, 1551

Nuutila, 1992, Glucose-free fatty acid cycle operates in heart and skeletal muscle in vivo, J Clin Invest, 89, 1767, 10.1172/JCI115780

Yamada, 1995, High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue, J Nucl Med, 36, 1301

Miyagawa, 2014, Positron emission tomography-computed tomography for imaging inflammatory cardiovascular disease, Circ J, 78, 1302, 10.1253/circj.CJ-14-0250

Bax, 1997, Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; A comparative study using different protocols, Eur J Nucl Med, 24, 35, 10.1007/BF01728306

Garfein, 2012, 565

Tang, 2015, Impact of patient preparation on the diagnostic performance of 18F-FDG PET in cardiac sarcoidosis: a systematic review and meta-analysis, Clin Nuc Med

Harisankar, 2011, Utility of high fat and low carbohydrate diet in suppressing myocardial FDG Uptake, J Nucl Cardiol, 18, 926, 10.1007/s12350-011-9422-8

Soussan, 2013, Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis, J Nucl Cardiol, 20, 120, 10.1007/s12350-012-9653-3

Cheng, 2010, Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: A randomized controlled trial, J Nucl Cardiol, 17, 286, 10.1007/s12350-009-9179-5

Kobayashi, 2013, Significant suppression of myocardial 18F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet, J Cardiol, 62, 314, 10.1016/j.jjcc.2013.05.004

Balink, 2011, Suppression of 18F-FDG myocardial uptake using a fat-allowed, carbohydrate-restricted diet, J Nucl Med Technol, 39, 185, 10.2967/jnmt.110.076489

Kumar, 2014, Effect of duration of fasting and diet on the myocardial uptake of fluoro-2-deoxyglucose (F-18 FDG) at rest, Indian J Nucl Med, 29, 140, 10.4103/0972-3919.136559

Coulden, 2012, Suppression of myocardial 18F-FDG uptake with a preparatory “Atkins-style” low-carbohydrate diet, Eur Radiol, 22, 2221, 10.1007/s00330-012-2478-2

Scholtens, 2016, Additional heparin pre-administration improves cardiac glucose metabolism over low carbohydrate diet alone in 18F-FDG-PET imaging, J Nucl Med, 57, 568, 10.2967/jnumed.115.166884

Lum, 2002, Reduction of myocardial 2-deoxy-2[18F]fluoro-d-glucose uptake artifacts in positron emission tomography using dietary carbohydrate restriction, Mol Imaging Biol, 4, 232, 10.1016/S1095-0397(01)00062-0

Lee, 2015, Comparison of myocardial F-18 uptake between overnight and non-overnight fasting in non-diabetic healthy subjects, Jpn J Radiol, 33, 385, 10.1007/s11604-015-0428-z

Asmal, 1979, A dose-response study of the anticoagulant and lipolytic activities of heparin in normal subjects, Br J Clin Pharmacol, 7, 531, 10.1111/j.1365-2125.1979.tb01000.x

Gaeta, 2011, Reduced myocardial 18F-FDG uptake after calcium channel blocker administration: Initial observation for a potential new method to improve plaque detection, Eur J Nucl Med Mol Imaging, 38, 2018, 10.1007/s00259-011-1873-2

2006, 6

Soejima, 2009, The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: With emphasis on the associated heart rhythm abnormalities, J Cardiovasc Electrophysiol, 20, 578, 10.1111/j.1540-8167.2008.01417.x

Patel, 2009, Detection of myocardial damage in patients with sarcoidosis, Circulation, 120, 1969, 10.1161/CIRCULATIONAHA.109.851352

Dorbala, 2013, SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0, J Nucl Med, 54, 1485, 10.2967/jnumed.112.105155

Vik-Mo, 1981, Influence of free fatty acids on myocardial oxygen consumption and ischemic injury, Am J Cardiol, 2, 361, 10.1016/0002-9149(81)90621-4